Female adnexal Wolffian tumors: A comparison of reported benign and malignant cases and STK11 adnexal tumors
Pathology - Research and Practice · 2026-07 · 283 · 156479
DOI: 10.1016/j.prp.2026.156479 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2026-07. Verfasst von Georgia Karpathiou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, University Hospital of Saint-Etienne, Saint-Etienne, France; Pathology Department, Tokyo Woman's Medical University Yachiyo Med…. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Adenoma, Adnexal Diseases. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Department, University Hospital of Saint-Etienne, Saint-Etienne, France; Pathology Department, Tokyo Woman's Medical University Yachiyo Medical Center (TYMC), Chiba, Japan. Electronic address: georgia.karpathi…
- Pathology Department, Tokyo Woman's Medical University Yachiyo Medical Center (TYMC), Chiba, Japan.
Zitieren
APA
Karpathiou, G., Nakazawa, T., & Hiroshima, K. (2026). Female adnexal Wolffian tumors: A comparison of reported benign and malignant cases and STK11 adnexal tumors. Pathology - Research and Practice, 283, 156479. https://doi.org/10.1016/j.prp.2026.156479
Vancouver
Karpathiou G, Nakazawa T, Hiroshima K. Female adnexal Wolffian tumors: A comparison of reported benign and malignant cases and STK11 adnexal tumors. Pathology - Research and Practice. 2026;283:156479. doi:10.1016/j.prp.2026.156479
BibTeX
@article{Karpathiou2026,
author = {Karpathiou, Georgia and Nakazawa, Tadao and Hiroshima, Kenzo},
title = {Female adnexal Wolffian tumors: A comparison of reported benign and malignant cases and STK11 adnexal tumors},
journal = {Pathology - Research and Practice},
year = {2026},
volume = {283},
pages = {156479},
doi = {10.1016/j.prp.2026.156479}
}
EUVIMED